The role of anorexigenic and orexigenic neuropeptides and peripheral signals on quartiles of weight loss in obese adolescents

Neuropeptides

Volumn 44, Issue 6, 2010, Pages 467-474

  Oyama, Lila Missae ^a   Nascimento, Claudia Maria Oller do ^a   Carnier, June ^a   Piano, Aline de ^a   Tock, Lian ^a   Sanches, Priscila de Lima ^a   Gomes, Fabíola Alvise Corrêa ^a   Tufik, Sergio ^a   Mello, Marco Túlio de ^a   Dâmaso, Ana R ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Adipokines; Adolescents; Energy regulation; Obesity; Therapy; Visceral fat

Indexed keywords

ALPHA INTERMEDIN; ANOREXIGENIC AGENT; GHRELIN; GLUCOSE; LEPTIN; NEUROPEPTIDE; NEUROPEPTIDE Y;

ADOLESCENT; ADULT; ANTHROPOMETRY; ARTICLE; BODY COMPOSITION; BODY MASS; DIETARY INTAKE; ENERGY BALANCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERLEPTINEMIA; INSULIN RESISTANCE; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; WEIGHT REDUCTION;

ADIPOSE TISSUE; ADOLESCENT; EATING; FEMALE; HUMANS; MALE; NEUROPEPTIDES; OBESITY; WEIGHT LOSS; YOUNG ADULT;

EID: 78349309394     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.npep.2010.07.002     Document Type: Article

References (42)

1. ACMS position stand on the appropriate intervention strategies for weight loss and prevention of weight regain for adults. Med. Sci. Sports. Exerc. 2001, 33(12):2145-2156. ACSM.
2. Baltatzi M., Hatzitolios A., Tziomalos K., Iliadis F., Zamboulis Ch. Neuropeptide Y and alpha-melanocyte-stimulating hormone: interaction in obesity and possible role in the development of hypertension. Int. J. Clin. Pract. 2008, 62(9):1432-1440.
3. Bloom S.R., Kuhajda F.P., Laher I., Pi-Sunyer X., Ronnett G.V., Tan T.M., et al. The obesity epidemic: pharmacological challenges. Mol. Interv. 2008, 8(2):82-98.
4. Centers for Disease Control and Prevention. Prevalence of over weight among children and adolescents: United States, 1999-2000. [Accessed 2004]. http://www.cdc.gov/nchs/products/pubs/pubd/hestats/overwght99.htm.
5. Cummings D.E., Weigle D.S., Frayo R.S., Breen P.A., Ma M.K., Dellinger E.P., Purnell J.Q. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N. Engl. J. Med. 2002, 346:1623-1630.
6. Dâmaso A.R., do Prado W.L., de Piano A., Tock L., Caranti D.A., Lofrano M.C., et al. Relationship between nonalcoholic fatty liver disease prevalence and visceral fat in obese adolescents. Dig. Liver Dis. 2008, 40(2):132-139.
7. De Ambrogi M., Volpe S., Tamanini C. Ghrelin central and peripheral effects of a novel peptydil hormone. Med. Sci. Monit. 2003, 9:217-224.
8. de Piano A., Prado W.L., Caranti D.A., Siqueira K.O., Stella S.G., Lofrano M., et al. Metabolic and nutritional profile of obese adolescents with non-alcoholic fatty liver disease (NAFLD). J. Pediatr. Gastroenterol. Nutr. 2007, 44(4):446-452.
9. Dubey S., Kabra M., Bajpai A., Pandey R.M., Hasan M., Gautam R.K., et al. Serum leptin levels in obese Indian children relation to clinical and biochemical parameters. Indian Pediatr. 2007, 44(4):257-262.
10. Dyck D. Adipokines as regulators of muscle metabolism and insulin sensitivity. Appl. Physiol. Metab. 2009, 34(3):396-402.
11. Fields D.A., Goran M.I. Body composition techniques and the four-compartment model in children. J. Appl. Physiol. 2000, 89(2):613-620.
12. Garcia J.M., Iyer D., Poston W.S., Marcelli M., Reeves R., Foreyt J., et al. Rise of plasma ghrelin with weight loss is not sustained during weight maintenance. Obesity (Silver Spring) 2006, 14:1716-1723.
13. Haider D.G., Schindler K., Prager G., Bohdjalian A., Luger A., Wolzt M., Ludvik B. Serum retinol-binding protein-4 is reduced after weight loss in morbidly obese subjects. J. Clin. Endocrinol. Metab. 2007, 92:1168-1171.
14. Hansen T.K., Dall R., Hosoda H., Kojima M., Kangawa K., Christiansen J.S., et al. Weight loss increases circulating levels of ghrelin in human obesity. Clin. Endocrinol. (Oxf) 2002, 56(2):203-206.
15. Hill R.J., Davies P.S. The validity of self-reported energy intake as determined using the doubly labeled water technique. Br. J. Nutr. 2001, 85:415-430.
16. Jéquier E. Leptin signaling, adiposity, and energy balance. Ann. N.Y. Acad. Sci. 2002, 967:379-388.
17. Kelishadi R., Hashemipour M., Mohammadifard N., Alikhassy H., Adeli K. Short- and long-term relationships of serum ghrelin with changes in body composition and the metabolic syndrome in prepubescent obese children following two different weight loss programmes. Clin. Endocrinol. (Oxf) 2008, 69:721-729.
18. Kim Y., Lee S. Physical activity and abdominal obesity in youth. Appl. Physiol. Nutr. Metabol. 2009, 34(4):571-581.
19. Klok M.D., Jakobsdottir S., Drent M.L. The role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review. Obes. Rev. 2007, 8(1):21-34.
20. Mancini M.C., Halpern A. Aspectos Fisiológicos do balanço energético. Arq. Bras. Endocrinol. Metabol. 2002, 46(3):230-248.
21. Marra F., Bertolani C. Adipokines in liver diseases. Hepatology 2009, 50(3):957-969.
22. Myers M.G., Cowley M.A., Münzberg H. Mechanisms of leptin action and leptin resistance. Annu. Rev. Physiol. 2008, 70:537-556.
23. Nobili V., Marcellini M., Devito R., Ciampalini P., Piemonte F., Comparcola D., et al. NAFLD in children: a Prospective Clinical-Pathological Study and Effect of Lifestyle Advice. Hepatology 2006, 44(2):458-465.
24. Dietary Reference Intake: applications in dietary assessment 2001, NRC, Washington, DC, National Academic Press.
25. Palou M., Sánchez J., Rodríguez A.M., Priego T., Picó C., Palou A. Induction of NPY/AgRP orexigenic peptide expression in rat hypothalamus is an early event in fasting: relationship with circulating leptin, insulin and glucose. Cell. Physiol. Biochem. 2009, 23(1-3):115-124.
26. Ramos E.J., Meguid M.M., Campos A.C., Coelho J.C. Neuropeptide Y, alpha-melanocyte-stimulating hormone, and monoamines in food intake regulation. Nutrition 2005, 21:269-279.
27. Reinehr T., Kersting M., Wollenhaupt A., Alexy U., Kling B., Ströbele K., Andler W. Evaluation of the training program 'OBELDICKS' for obese children and adolescents. Klinische Pädiatrie 2005, 217:1-8.
28. Reinehr T., de Sousa G., Roth C.L.I. Obestatin and ghrelin levels in obese children and adolescents before and after reduction of overweight. Clin. Endocrinol. (Oxf) 2008, 68(2):304-310.
29. Ribeiro-Filho F.F., Faria A.N., Azjen S., Zanella M.T., Ferreira S.R. Methods of estimation of visceral fat: advantages of ultrasonography. Obes. Res. 2003, 11:1488-1494.
30. Roberts C.K., Berger J.J., Barnard R.J. Long-term effects of diet on leptin, energy intake, and activity in a model of diet-induced obesity. J. Appl. Physiol. 2002, 93(3):887-893.
31. Roth C.L., Enriori P.J., Gebhardt U., Hinney A., Müller H.L., Hebebrand J., Reinehr T., Cowley M.A. Changes of peripheral α-melanocyte-stimulating hormone in childhood obesity. Metab. Clin. Exp. 2010, (59):186-194.
32. Schwimmer J.B., Deutsch R., Rauch J.B., Behling C., Newbury R., Lavine J.E. Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease. J. Pediatr. 2003, 143(4):500-505.
33. Shimizu H., Inoue K., Mori M. The leptin-dependent and -independent melanocortin signaling system: regulation of feeding and energy expenditure. J. Endocrinol. 2007, 193:1-9.
34. Simpson K.A., Martin N.M., Bloom S.R. Hypothalamic regulation of food intake and clinical therapeutic applications. Arq. Bras. Endocrinol. Metabol. 2009, 53(2):120-128.
35. Soriano-Guillen L., Barrios V., Campos-Barros A., Argente J. Ghrelin levels in obesity and anorexia nervosa: effect of weight reduction or recuperation. J. Pediatr. 2004, 144:36-42.
36. Stanton R.A. Nutrition problems in an obesogenic environment. Med. J. Aust. 2006, 184(2):76-79.
37. Tanner J.M., Whitehouse R.H. Clinical Longitudinal standards for height, weight velocity and stages of puberty. Arch. Dis. Child. 1976, 51:170-179.
38. Tock L., Prado W.L., Caranti D.A., Cristofalo D.M., Lederman H., Fisberg M., et al. Non-alcoholic fatty liver disease in obese adolescents after multidisciplinary therapy. Eur. J. Gastroenterol. Hepatol. 2006, 18(12):1241-1245.
39. Trayhurn P., Bing C. Appetite and energy balance signals from adipocytes. Philos. Trans. R. Soc. London, B. Biol. Sci. 2006, 361(1471):1237-1249.
40. Valassi E., Scacchi M., Cavagnini F. Neuroendocrine control of food intake. Nutr. Metab. Cardiovasc. Dis. 2008, 18(2):158-168.
41. Velloso L.A. O controle hipotalâmico da fome e da termogênese - implicações no desenvolvimento da obesidade. Arq. Bras. Endocrinol. Metabol. 2006, 50(2):165-176.
42. Yang L., Scott K.A., Hyun J., Tamashiro K.L., Tray N., Moran T.H., Bi S. Role of dorsomedial hypothalamic neuropeptide Y in modulating food intake and energy balance. J. Neurosci. 2009, 29(1):179-190.